Dimensional Fund Advisors’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.2M | Sell |
40,886
-895
| -2% | -$26.3K | ﹤0.01% | 2860 |
|
2025
Q1 | $1.07M | Buy |
41,781
+7,762
| +23% | +$200K | ﹤0.01% | 2868 |
|
2024
Q4 | $983K | Sell |
34,019
-154
| -0.5% | -$4.45K | ﹤0.01% | 2918 |
|
2024
Q3 | $812K | Sell |
34,173
-3,017
| -8% | -$71.7K | ﹤0.01% | 2943 |
|
2024
Q2 | $644K | Buy |
37,190
+13,653
| +58% | +$236K | ﹤0.01% | 2986 |
|
2024
Q1 | $526K | Buy |
23,537
+7,038
| +43% | +$157K | ﹤0.01% | 3034 |
|
2023
Q4 | $303K | Buy |
16,499
+1,918
| +13% | +$35.2K | ﹤0.01% | 3134 |
|
2023
Q3 | $253K | Sell |
14,581
-444
| -3% | -$7.71K | ﹤0.01% | 3177 |
|
2023
Q2 | $273K | Buy |
15,025
+7,631
| +103% | +$139K | ﹤0.01% | 3182 |
|
2023
Q1 | $127K | Buy |
7,394
+348
| +5% | +$5.97K | ﹤0.01% | 3275 |
|
2022
Q4 | $164 | Buy |
7,046
+5,524
| +363% | +$129 | ﹤0.01% | 3258 |
|
2022
Q3 | $34K | Buy |
+1,522
| New | +$34K | ﹤0.01% | 3439 |
|